.full-width-5aaf7ba976ca9 { min-height:100px; padding:10px 0 10px; margin-bottom:10px; } #background-layer--5aaf7ba976ca9 { background-position:left top; background-repeat:repeat; ; }

December, 2014 – Knock-in mouse model of AHC (D801N mutation) demonstrates that mice closely mimic AHC symptoms found in humans. Significant step towards the processes of preparing for clinical trials to treat and eventually Cure AHC and other ATP1A3 dysfunction disorders. Read More

July, 2014 – Alternating Hemiplegia of Childhood mutations have a differential effect on Na+,K+-ATPase activity and ouabain binding. Suggests physiological explanation for the genotype/phenotype correlations noted in previous studies.  Read More

March 20, 2013 – New Research Offers Hope For Novel Treatments For AHC
In a  peer-reviewed research article published March 20, 2013 by the School of Biomedical Sciences, University of Leeds in the United Kingdomentitled Alternating Hemiplegia of Childhood-Related Neural and Behavioural Phenotypes in Na+,K+-ATPase α3 Missense Mutant Mice, offers hope for novel treatments for Alternating Hemiplegia of Childhood (AHC).

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search